Skip to main content

Table 5 Scenario analysis results

From: The cost-effectiveness analysis of newborn screening for inherited metabolic disorders in China using tandem mass spectrometry: a real-world evidence

Item

Screening group

non-screening group

ICER(CNY/QALY)

(screening vs. non screening)

Scenario 1(Assume false negative was 3%)

 Total cost (CNY)

1,001,853

157,303

71,084

 QALYs

15.85

3.97

Scenario 2(Assume false negative was 10%)

 Total cost (CNY)

1,003,254

157,303

75,157

 QALYs

15.22

3.97

Scenario 3(Assume cost discount rate was 3%)

 Total cost (CNY)

1008068.117

202573.5775

64,407

 QALYs

16.47

3.97

Scenario 4(Assume cost discount rate was 1%)

 Total cost (CNY)

1,023,691

285,458

59,029

 QALYs

16.47

3.97